Infanrix hexa
Details for Infanrix hexa vaccine and its components.
Registered for use in infants and children aged ≥6 weeks.
DTPa-hepB-IPV-Hib — diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccine
The vaccine consists of both a 0.5 mL monodose pre-filled syringe and a vial containing a lyophilised pellet.
The pre-filled syringe contains:
- ≥30 IU diphtheria toxoid
- ≥40 IU tetanus toxoid
- 25 µg pertussis toxoid
- 25 µg filamentous haemagglutinin
- 8 µg pertactin
- 10 µg recombinant hepatitis B surface antigen (HBsAg)
- 40 D-antigen units inactivated poliovirus type 1 (Mahoney)
- 8 D-antigen units inactivated poliovirus type 2 (MEF-1)
- 32 D-antigen units inactivated poliovirus type 3 (Saukett)
Adsorbed onto aluminium hydroxide/phosphate.
Also contains traces of:
- formaldehyde
- polysorbate 80
- polysorbate 20
- polymyxin
- neomycin
The vial containing a lyophilised pellet contains:
- 10 µg purified Hib capsular polysaccharide conjugated to 20–40 µg tetanus toxoid
May contain yeast proteins.
The product information and consumer medicine information for Infanrix hexa have more details.
Page history
Definitions
- DTPa
- diphtheria-tetanus-acellular pertussis vaccine
- IPV
- inactivated poliomyelitis vaccine
- IU
- international units
- HBsAg
- hepatitis B surface antigen
This document was printed on: 24/01/2019. Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/infanrix-hexa.